Местное лечение боли: эффективность и переносимость препарата «Версатис» – пластин с 5% лидокаином для накожного применения
Ананьева Л.П. Местное лечение боли: эффективность и переносимость препарата «Версатис» – пластин с 5% лидокаином для накожного применения. Consilium Medicum. 2008; 10 (7): 103–108.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Argoff CE. New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000; 16: S62–6.
2. Ritchie JM, Greene NM. Local anaesthetics. AG.Gilman, TW.Rail, AS/Nies et al. (eds.). The pharmacological basis of therapeutics. 8th ed. Singapore: McGraw-Hill, Inc. 1992; 311–31.
3. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23 (4): 361–74
4. Campbell BJ, Rowbotham M, Davies PS et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002; 91 (5): 1343–50.
5. Rowbotham MC, Davies PS, Verkempinck C et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65 (1): 39–44.
6. Rowbotham MC, Davies PS, Galer BS. Multicenter. double-blind, vehicle-controlled trial of long term use of lidocaine patches for postherpetic neuralgia. In: 8th World Congress on Pain – Abstracts. Seattle (WA): IASP Press, 1996; 274.
7. Galer BS, Jensen MP, Ma T et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18 (5): 297–301.
8. Galer BS, Rowbotham MC, Perander J et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80 (3): 533–8.
9. Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64 (9): 937–47.
10. Attal N, Cruiccu G, Haanpaa P et al. Treatment of neuropathic paun. R. Hudges e.a.(eds) European Handbook of Neurological Management. Blackwell Publishing Ltd. 2006; 412–32.
11. Fennerup NB, Otto M, McQuay NJ. Algoritm of neuropathic pain treatment. Pain 2005; 118: 289–305.
12. White WT, Patel N, Drass M et al. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med 20053; 4: 321–30.
13. Кivitz AJ et al. Arthritis Rheum 2005; 52 (S9): 507–8.
14. Nalamachu S, Crockett RS, Gammaitoni AR et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. Med Gen Med 2006, 9 (8): 33.
15. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002; 36 (2): 236–40.
16. Baron R, Binder A, Boesl I et al. Long-term efficacy, safety and quality of life with lidocaine 5% medicated plaster in post-herpetic neuralgia. Eur J Pain 2006; 10 (S1): 205.
17. Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continuously applied lidocaine patches 5%. Am J Health Syst Pharm 2002; 59 (22): 2215–20.
2. Ritchie JM, Greene NM. Local anaesthetics. AG.Gilman, TW.Rail, AS/Nies et al. (eds.). The pharmacological basis of therapeutics. 8th ed. Singapore: McGraw-Hill, Inc. 1992; 311–31.
3. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23 (4): 361–74
4. Campbell BJ, Rowbotham M, Davies PS et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002; 91 (5): 1343–50.
5. Rowbotham MC, Davies PS, Verkempinck C et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65 (1): 39–44.
6. Rowbotham MC, Davies PS, Galer BS. Multicenter. double-blind, vehicle-controlled trial of long term use of lidocaine patches for postherpetic neuralgia. In: 8th World Congress on Pain – Abstracts. Seattle (WA): IASP Press, 1996; 274.
7. Galer BS, Jensen MP, Ma T et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18 (5): 297–301.
8. Galer BS, Rowbotham MC, Perander J et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80 (3): 533–8.
9. Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64 (9): 937–47.
10. Attal N, Cruiccu G, Haanpaa P et al. Treatment of neuropathic paun. R. Hudges e.a.(eds) European Handbook of Neurological Management. Blackwell Publishing Ltd. 2006; 412–32.
11. Fennerup NB, Otto M, McQuay NJ. Algoritm of neuropathic pain treatment. Pain 2005; 118: 289–305.
12. White WT, Patel N, Drass M et al. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med 20053; 4: 321–30.
13. Кivitz AJ et al. Arthritis Rheum 2005; 52 (S9): 507–8.
14. Nalamachu S, Crockett RS, Gammaitoni AR et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. Med Gen Med 2006, 9 (8): 33.
15. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002; 36 (2): 236–40.
16. Baron R, Binder A, Boesl I et al. Long-term efficacy, safety and quality of life with lidocaine 5% medicated plaster in post-herpetic neuralgia. Eur J Pain 2006; 10 (S1): 205.
17. Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continuously applied lidocaine patches 5%. Am J Health Syst Pharm 2002; 59 (22): 2215–20.
Авторы
Л.П.Ананьева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.